SCHEMBL24328580

SCHEMBL24328580

Cc1cccc2c1N(S(=O)(=O)N(C)C)CC2

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.55
ALOX12 P18054 1/20 0.44
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
CNR2 P34972 1/20 0.40
ALDH1A1 P00352 2/20 0.38
HTT P42858 2/20 0.38
MAPT P10636 1/20 0.38
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
HTR2C P28335 2/20 0.37
HTR2B P41595 1/20 0.37
GAA P10253 2/20 0.36
POLB P06746 1/20 0.36
DRD2 P14416 1/20 0.36
DRD4 P21917 1/20 0.36
LMNA P02545 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TUBB4A P04350 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14591313 0.82 ALOX12 (0.47) KDM4EALOX12MEN1KMT2ACNR2
SCHEMBL26777839 0.81 KDM4E (0.38) KDM4EMEN1KMT2AALDH1A1GAA
SCHEMBL24326990 0.79 MAPT (0.46) KDM4EALOX12MEN1KMT2ACNR2
SCHEMBL24328575 0.78 ALOX12 (0.44) KDM4EALOX12MEN1KMT2ACNR2
SCHEMBL24328578 0.78 ALOX12 (0.44) KDM4EALOX12MEN1KMT2ACNR2
SCHEMBL24326993 0.78 ALOX12 (0.44) KDM4EALOX12MEN1KMT2ACNR2
SCHEMBL24328583 0.77 ALOX12 (0.43) KDM4EALOX12MEN1KMT2ACNR2
SCHEMBL24326991 0.76 ALOX12 (0.42) KDM4EALOX12MEN1KMT2ACNR2
SCHEMBL24326989 0.76 ALOX12 (0.46) KDM4EALOX12MEN1KMT2ACNR2
SCHEMBL29015738 0.76 KMT2A (0.54) MEN1KMT2AALDH1A1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022063106-A1 INDOLINE COMPOUNDS AND DERIVATIVES AS EGFR INHIBITORS BEIGENE, LTD. (KY) 2022-03-31 WO disclosed